Skip to main content
. 2013 May 8;6(1):3–8. doi: 10.3892/ol.2013.1334

Table III.

Stratification analysis of the p38β promoter region polymorphism (rs2235356, -1628A>G) genotypes by selected variables in patients with CRC and cancer-free control subjects.

Variable No. cases (n=855) (%)
No. controls (n=871) (%)
Crude OR (95% CI) AG+GG vs. AA Adjusted ORa (95% CI) AG+GG vs. AA P-valueb
AA AG+GG AA AG+GG
Age (years) 0.2772
  ≤60 103 (23.8) 329 (76.2) 182 (39.9) 274 (60.1) 2.12 (1.59–2.84) 2.11 (1.56–2.87)
  > 60 111 (26.2) 312 (73.8) 161 (38.8) 254 (61.2) 1.78 (1.33–2.39) 1.97 (1.43–2.72)
Gender 0.2622
  Male 135 (25.9) 386 (74.1) 204 (38.6) 325 (61.4) 1.80 (1.38–2.33) 1.82 (1.36–2.44)
  Female 79 (23.7) 255 (76.3) 139 (40.6) 203 (59.4) 2.21 (1.59–3.08) 2.10 (1.50–2.94)
Smoking status 0.0770
  Smoker 112 (27.1) 302 (72.9) 154 (37.9) 252 (62.1) 1.65 (1.23–2.21) 1.68 (1.20–2.35)
  Non-smoker 102 (23.1) 339 (76.9) 189 (40.6) 276 (59.4) 2.28 (1.71–3.04) 2.22 (1.66–2.97)
Drinking status 0.0501
  Not teetotal 114 (28.5) 286 (71.5) 76 (37.3) 128 (62.7) 1.49 (1.04–2.13) 1.47 (1.02–2.12)
  Teetotal 100 (22.0) 355 (78.0) 267 (40.0) 400 (60.0) 2.37 (1.81–3.11) 2.37 (1.79–3.14)
BMI (kg/m2) 0.3030
  <18 9 (16.1) 47 (83.9) 12 (34.3) 23 (65.7) 2.72 (1.01–7.39) 3.63 (1.01–13.0)
  18–25 129 (23.2) 428 (76.8) 231 (38.0) 377 (62.0) 2.03 (1.57–2.63) 2.01 (1.53–2.62)
  >25 76 (31.4) 166 (68.6) 100 (43.9) 128 (56.1) 1.71 (1.17–2.49) 1.94 (1.29–2.92)
Family history of cancer 0.0578
  Yes 23 (24.0) 73 (76.0) 19 (26.4) 53 (73.6) 1.14 (0.56–2.30) 1.04 (0.49–2.21)
  No 191 (25.2) 568 (74.8) 324 (40.5) 475 (59.5) 2.03 (1.63–2.52) 2.12 (1.69–2.66)
a

Adjusted for age, gender, smoking status, alcohol use, body mass index (BMI) and family history of cancer in a logistic regression model;

b

calculated using a standard unconditional logistic regression model for the multiplicative interactions between the rs2235356 1628A>G polymorphism and selected variables. OR, odds ratio; CI, confidence interval; CRC, colorectal cancer.